2001
DOI: 10.1097/00128360-200104000-00001
|View full text |Cite
|
Sign up to set email alerts
|

Multimodal Hyperspectral Imaging for the Noninvasive Diagnosis of Cervical Neoplasia

Abstract: H ealth care professionals encounter multiple dilemmas with the surveillance, diagnosis, and management of women with cervical neoplasia. An imperfect screening test, a lengthy Papanicolaou (Pap) smear collection to notification interval, and a substantial patient noncompliance rate with recommended practices may all adversely impact the screening process [1][2][3][4][5][6][7][8]. Cervical neoplasia is suspected from an abnormal screening Pap smear or positive triage test for oncogenic human papillomavirus (HP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
47
1
3

Year Published

2003
2003
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(53 citation statements)
references
References 18 publications
2
47
1
3
Order By: Relevance
“…3a and b), Barrett's oesophagus [10] and the colon [11] clinical trials have shown an improvement in the relative sensitivity, and better contrast when combining white light endoscopy with autofluorescence and/or reflectance spectroscopy as compared to white light endoscopy alone. Similar conclusions have been reached for cervical tissue diagnosis [15,16]. The commercial instruments here include the FDA-approved LUMA TM Cervical Imaging System (MediSpectra, MA, USA) and the LightTouch system (Norcross, GA, USA).…”
Section: Clinical Applications Of Spectroscopic Techniquessupporting
confidence: 60%
“…3a and b), Barrett's oesophagus [10] and the colon [11] clinical trials have shown an improvement in the relative sensitivity, and better contrast when combining white light endoscopy with autofluorescence and/or reflectance spectroscopy as compared to white light endoscopy alone. Similar conclusions have been reached for cervical tissue diagnosis [15,16]. The commercial instruments here include the FDA-approved LUMA TM Cervical Imaging System (MediSpectra, MA, USA) and the LightTouch system (Norcross, GA, USA).…”
Section: Clinical Applications Of Spectroscopic Techniquessupporting
confidence: 60%
“…100,116,121 Auto-fluorescence imaging is technically easy to implement during patient screening or surgery and therefore it does not require expensive equipment or complex regulatory approvals. Endoscopic and wide-field auto-fluorescence imaging has been considered for screening oral, 38,83,90,117,161,175 laryngeal, 8,112,220 cervical, 54,84,193 gastric 55,72 and colorectal 88,186 cancer. Lane et al 117 reported a 98 and 100% increase of sensitivity and specificity using autofluorescence imaging in 44 patients screened for oral dysplasia or cancer, while Kraft et al 112 observed a superior performance of autofluorescence (sensitivity 91%, specificity 84%) endoscopy compared to white light (sensitivity 73%, specificity 79%) and even aminolevulinic acid (ALA) induced fluorescence (sensitivity 95%, specificity 62%) endoscopy.…”
Section: Auto-fluorescence Imaging (Endogenous Contrast)mentioning
confidence: 99%
“…A computerized, algorithm-based, automated evaluation colposcopic device could help novice colposcopists identify and sample lesions determined to represent significant neoplasia. Because both use computer-based platforms, the automated image analysis tool easily could interface with fluorescent and reflective spectroscopy units to improve diagnostic accuracy [8][9][10]. Such an image analysis instrument also would help researchers analyze the NCI cervical image archive.…”
Section: Automated Classificationmentioning
confidence: 99%